logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Dhanoa, Kanwardeep Singh
    Pharmacist born in December 1977
    Individual (20 offsprings)
    Officer
    icon of calendar 2023-11-01 ~ now
    OF - Director → CIF 0
    Mr Kanwardeep Singh Dhanoa
    Born in December 1977
    Individual (20 offsprings)
    Person with significant control
    icon of calendar 2022-11-07 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Patel, Mitul Harshad
    Pharmacist born in June 1981
    Individual (35 offsprings)
    Officer
    icon of calendar 2023-11-01 ~ now
    OF - Director → CIF 0
    Mr Mitul Harshad Patel
    Born in June 1981
    Individual (35 offsprings)
    Person with significant control
    icon of calendar 2022-11-07 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 3
    Key, Jeremy Andrew
    Pharmacist born in March 1987
    Individual (3 offsprings)
    Officer
    icon of calendar 2022-11-07 ~ now
    OF - Director → CIF 0
    Mr Jeremy Andrew Key
    Born in March 1987
    Individual (3 offsprings)
    Person with significant control
    icon of calendar 2022-11-07 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

KESSINGLAND PHARMA LTD

Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Intangible Assets
1,120,583 GBP2024-11-30
1,180,083 GBP2023-11-30
Property, Plant & Equipment
21,831 GBP2024-11-30
22,064 GBP2023-11-30
Fixed Assets
1,142,414 GBP2024-11-30
1,202,147 GBP2023-11-30
Total Inventories
57,099 GBP2024-11-30
25,736 GBP2023-11-30
Debtors
171,213 GBP2024-11-30
168,093 GBP2023-11-30
Cash at bank and in hand
135,988 GBP2024-11-30
72,264 GBP2023-11-30
Current Assets
364,300 GBP2024-11-30
266,093 GBP2023-11-30
Net Current Assets/Liabilities
-78,076 GBP2024-11-30
-190,531 GBP2023-11-30
Total Assets Less Current Liabilities
1,064,338 GBP2024-11-30
1,011,616 GBP2023-11-30
Creditors
Non-current
-856,611 GBP2024-11-30
-958,139 GBP2023-11-30
Net Assets/Liabilities
207,727 GBP2024-11-30
53,477 GBP2023-11-30
Equity
Called up share capital
3 GBP2024-11-30
3 GBP2023-11-30
Retained earnings (accumulated losses)
207,724 GBP2024-11-30
53,474 GBP2023-11-30
Average Number of Employees
82023-12-01 ~ 2024-11-30
82022-11-07 ~ 2023-11-30
Intangible Assets - Gross Cost
Net goodwill
1,190,000 GBP2024-11-30
1,190,000 GBP2023-11-30
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
69,417 GBP2024-11-30
9,917 GBP2023-11-30
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
59,500 GBP2023-12-01 ~ 2024-11-30
Intangible Assets
Net goodwill
1,120,583 GBP2024-11-30
1,180,083 GBP2023-11-30
Property, Plant & Equipment - Gross Cost
Land and buildings, Under hire purchased contracts or finance leases
12,397 GBP2024-11-30
12,397 GBP2023-11-30
Furniture and fittings
12,000 GBP2024-11-30
10,000 GBP2023-11-30
Property, Plant & Equipment - Gross Cost
24,397 GBP2024-11-30
22,397 GBP2023-11-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
2,566 GBP2024-11-30
333 GBP2023-11-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
2,566 GBP2024-11-30
333 GBP2023-11-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings
2,233 GBP2023-12-01 ~ 2024-11-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
2,233 GBP2023-12-01 ~ 2024-11-30
Property, Plant & Equipment
Land and buildings, Under hire purchased contracts or finance leases
12,397 GBP2024-11-30
12,397 GBP2023-11-30
Furniture and fittings
9,434 GBP2024-11-30
9,667 GBP2023-11-30
Trade Debtors/Trade Receivables
Current
138,701 GBP2024-11-30
131,729 GBP2023-11-30
Trade Creditors/Trade Payables
Current
150,684 GBP2024-11-30
137,958 GBP2023-11-30
Other Taxation & Social Security Payable
Current
70,204 GBP2024-11-30
18,669 GBP2023-11-30
Bank Borrowings/Overdrafts
Non-current
856,611 GBP2024-11-30
958,139 GBP2023-11-30

  • KESSINGLAND PHARMA LTD
    Info
    Registered number 14467019
    icon of address205 Plumstead Road, Norwich NR1 4AB
    Private Limited Company incorporated on 2022-11-07 (3 years). The company status is Active.
    The last date of confirmation statement was made at 2024-11-01
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 16 October 2025 and licensed under the Open Government Licence v3.0.